Related Experiment Video

Updated: Aug 19, 2026

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding
08:20

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding

Published on: May 1, 2020

Pharmacological control of surgical scar tissue

E E Peacock

    The American Surgeon
    |November 1, 1978
    PubMed

    Insights

    Researchers are exploring pharmacological methods to control scar tissue formation. Beta-aminopropionitrile (BAPN) shows promise in preventing abnormal collagen development and may soon enable safe clinical control of scar tissue properties.

    Area of Science:

    • Biomedical Science
    • Pharmacology
    • Tissue Engineering

    Background:

    • Scar tissue formation is a complex biological process.
    • Current methods for managing excessive scarring are limited.
    • Pharmacological interventions offer a potential avenue for scar tissue control.

    Purpose of the Study:

    • To investigate the potential of pharmacological agents for controlling scar tissue.
    • To evaluate the efficacy and safety of proline analogues and Beta-aminopropionitrile (BAPN) in scar prevention.
    • To explore the future possibilities of combining BAPN with other drugs for enhanced scar management.

    Main Methods:

    • Administration of proline analogues to inhibit collagen helical structure.
    • Controlled induction of lathyrism using Beta-aminopropionitrile (BAPN).
    • Testing of BAPN in preclinical models and clinical trials for various fibrotic conditions.

    Main Results:

    • Proline analogues showed toxicity, limiting human application.
    • Highly purified BAPN demonstrated selective lathyrogenic effects on healing wounds with apparent non-toxicity.
    • BAPN has been tested in patients with conditions like scleroderma and keloids.

    Conclusions:

    • Pharmacological control of scar tissue is theoretically possible and practically demonstrated in animal models.
    • Beta-aminopropionitrile (BAPN) is a promising agent for modulating scar tissue properties.
    • Combination therapy with agents like Colchicine may lead to safe and effective clinical control of scar tissue within two years.

    More Related Videos

    Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay07:40

    Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

    Published on: April 28, 2022

    A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring05:54

    A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

    Published on: November 29, 2024

    Related Concept Videos

    Clinical Applications of Epidermal Stem Cells01:19

    Clinical Applications of Epidermal Stem Cells

    Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
    Phases of Wound Repair01:28

    Phases of Wound Repair

    Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
    Formation of Blood Clot
    In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
    Healing II: Complications01:24

    Healing II: Complications

    Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...